Imura Hajime, Modi Paul, Pawade Ashwinikumar, Parry Andrew J, Suleiman M Saadeh, Angelini Gianni D, Caputo Massimo
Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom.
Ann Thorac Surg. 2002 Dec;74(6):1998-2002. doi: 10.1016/s0003-4975(02)04030-4.
Cardiac troponin I (TnI) is a sensitive and specific marker of myocardial injury, but little is known about its release after complex congenital heart surgery. We investigated whether TnI correlates with early clinical outcome in neonates undergoing the arterial switch operation (ASO) for transposition of the great arteries (TGA).
Troponin I was measured serially up to 48 hours postoperatively in 31 neonates undergoing the ASO alone (simple TGA) and 9 neonates undergoing the ASO combined with other procedures (complex TGA) (eg, closure of a ventricular septal defect) and correlated with intraoperative and postoperative clinical parameters.
There was no mortality. Troponin I peaked at either 4 or 12 hours postoperatively in all patients (median for simple TGA = 3.4 ng/mL, interquartile range 2.4 to 4.6; median for complex TGA = 4.7 ng/mL, interquartile range 3.2 to 6.8, p = 0.20). Peak TnI correlated with the durations of inotropic support (r = 0.54, p < 0.001), ventilation (r = 0.51, p < 0.01), and intensive care unit stay (r = 0.50, p < 0.01). The duration of cardiopulmonary bypass, aortic cross-clamping, and circulatory arrest did not correlate with the peak or total TnI release. The duration of aortic cross-clamping correlated poorly with the duration of inotropic support (r = 0.40, p < 0.05). The complex TGA group had longer aortic cross-clamp times, required more postoperative inotropic support, and had significantly higher total TnI release compared with the simple TGA group.
There are weak but statistically significant correlations between peak TnI and clinical outcome. Complexity of the defect and ischemic times may be as useful to predict outcome in this group of patients.
心肌肌钙蛋白I(TnI)是心肌损伤的敏感且特异的标志物,但对于其在复杂先天性心脏病手术后的释放情况知之甚少。我们研究了在接受大动脉转位(TGA)的动脉调转术(ASO)的新生儿中,TnI是否与早期临床结局相关。
对31例仅接受ASO(单纯TGA)的新生儿和9例接受ASO联合其他手术(复杂TGA)(如室间隔缺损修补)的新生儿术后连续48小时测定肌钙蛋白I,并将其与术中和术后临床参数相关联。
无死亡病例。所有患者的TnI在术后4小时或12小时达到峰值(单纯TGA组中位数 = 3.4 ng/mL,四分位间距2.4至4.6;复杂TGA组中位数 = 4.7 ng/mL,四分位间距3.2至6.8,p = 0.20)。TnI峰值与正性肌力药物支持时间(r = 0.54,p < 0.001)、通气时间(r = 0.51,p < 0.01)和重症监护病房停留时间(r = 0.50,p < 0.01)相关。体外循环、主动脉阻断和循环停滞时间与TnI峰值或总释放量无关。主动脉阻断时间与正性肌力药物支持时间相关性较差(r = 0.40,p < 0.05)。与单纯TGA组相比,复杂TGA组主动脉阻断时间更长,术后需要更多的正性肌力药物支持,且总TnI释放量显著更高。
TnI峰值与临床结局之间存在微弱但具有统计学意义的相关性。缺损的复杂性和缺血时间可能同样有助于预测该组患者的结局。